Berlin and Brandenburg offer excellent development opportunities. The region features a unique environment with many universities and research institutes, which ease the startup for 10 to 20 biotechnology companies each year. Six technology parks within close reach add a convenience that is unique for Germany.
Many networking opportunities facilitate the collaboration between business and science. These networks have given our university hospitals the lead in the nation when it comes to securing grants and subsidies. The region offers a unique technical infrastructure. The private and commercial rental rates compare favorably with metropolitan cities in Germany and the world, and living expenses are low.
The region is home to 6 million people who are not only potential customers but also an excellent pool of highly qualified employees. Scientists from renowned academic institutions around the world have responded to the attraction of our region.
Next to the US and Japan, Germany is the third largest market for the pharmaceutical industry. 80 Million residents make a significant market for foreign companies. An additional advantage is the fact that the most relevant German authorities have their headquarters in Berlin-Brandenburg. The presence of the Robert-Koch Institute offers still more benefits as a central research and reference facility of the Federal German Ministry of Health for the biomedical sciences and the gene technology.
Especially American and Asian companies will experience our metropolitan region as an ideal site for their research projects. Proprietary research and developments in Berlin-Brandenburg as well as strategic alliances with local companies facilitate innovations and approvals. Although the infrastructure is exceptional, the cost of setting up the requirements for R&D are significantly lower than elsewhere in the world.